Exon 2, which harbors the start codon and transmembrane intracellular domains of SGCD, is targeted in a genetically modified mouse Duchenne muscular dystrophy (DMD) model [24, 25]. The gene discussed is SGCD; the disease is Duchenne muscular dystrophy.